Genscript Biotech Names New Company Secretary and Authorised Representative

Genscript Biotech ( (HK:1548) ) has issued an announcement.

Genscript Biotech Corporation has announced a change in its corporate governance personnel, with company secretary and authorised representative Ms. Wong Wai Ling resigning effective 15 March 2026. The board noted that Ms. Wong has no disagreement with directors and that there are no issues related to her departure requiring attention from the exchange or shareholders.

The company has appointed Ms. Lam Wai Yee Sophie as the new company secretary and authorised representative under Hong Kong’s Companies Ordinance, also effective 15 March 2026. With over 20 years of company secretarial and compliance experience for listed companies, and multiple professional governance qualifications, Ms. Lam’s appointment is expected to support Genscript’s ongoing compliance and corporate governance practices.

The most recent analyst rating on (HK:1548) stock is a Sell with a HK$13.00 price target. To see the full list of analyst forecasts on Genscript Biotech stock, see the HK:1548 Stock Forecast page.

More about Genscript Biotech

Genscript Biotech Corporation is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange, operating in the biotech sector. The company is governed by a board comprising executive and independent non-executive directors, reflecting a typical governance structure for a Hong Kong–listed life sciences enterprise.

YTD Price Performance: -10.71%

Average Trading Volume: 8,496,016

Technical Sentiment Signal: Sell

Current Market Cap: HK$24.12B

See more insights into 1548 stock on TipRanks’ Stock Analysis page.